Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bio-Reference Laboratories Company Profile (NASDAQ:BRLI)

Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $33.60 (0.21% upside)

Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/23/2014ZacksUpgradeNeutral -> Outperform$33.60ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014William BlairReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
8/28/2014Bank of AmericaDowngradeUnderperformViewTweet This Rating  Share This Rating on StockTwits
1/20/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
12/10/2013Bank of AmericaReiterated RatingBuy$34.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
11/27/2013SidotiDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/10/2013William BlairDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Benchmark Co.Boost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2013Benchmark Co.Boost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 2/1/2013 forward)